Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age

Similar articles for PMID: 1319075

Showing 1 to 12 of 165 entries
Sorted by: Best Match Show Resources per page
Gadolinium-DTPA enhanced magnetic resonance imaging of bone and soft tissue sarcomas in comparison with pathological findings.

Acta medica Okayama

Ozaki T, Inoue H, Taguchi K, Sugihara S.
PMID: 1485542
Acta Med Okayama. 1992 Dec;46(6):471-7. doi: 10.18926/AMO/32641.

We compared gadolinium diethylenetriaminepentaacetic acid (Gd-DTPA) enhanced T1-weighted images (T1-Gd) with the histopathological findings in 13 patients with bone or soft tissue sarcomas. Signal intensity of the viable tumor tissue was increased in T1-Gd in 92% of the patients....

Cite
Ozaki T, Inoue H, Taguchi K, et al. Gadolinium-DTPA enhanced magnetic resonance imaging of bone and soft tissue sarcomas in comparison with pathological findings. Acta Med Okayama. 1992;46(6):471-7doi: 10.18926/AMO/32641.
Ozaki, T., Inoue, H., Taguchi, K., & Sugihara, S. (1992). Gadolinium-DTPA enhanced magnetic resonance imaging of bone and soft tissue sarcomas in comparison with pathological findings. Acta medica Okayama, 46(6), 471-7. https://doi.org/10.18926/AMO/32641
Ozaki, T, et al. "Gadolinium-DTPA enhanced magnetic resonance imaging of bone and soft tissue sarcomas in comparison with pathological findings." Acta medica Okayama vol. 46,6 (1992): 471-7. doi: https://doi.org/10.18926/AMO/32641
Ozaki T, Inoue H, Taguchi K, Sugihara S. Gadolinium-DTPA enhanced magnetic resonance imaging of bone and soft tissue sarcomas in comparison with pathological findings. Acta Med Okayama. 1992 Dec;46(6):471-7. doi: 10.18926/AMO/32641. PMID: 1485542.
Copy Download .nbib Format: NLM
Response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy: assessment with dynamic and static MR imaging and skeletal scintigraphy.

Investigative radiology

Shapeero LG, Henry-Amar M, Vanel D.
PMID: 1464523
Invest Radiol. 1992 Nov;27(11):989-91.

No abstract available.

Cite
Shapeero LG, Henry-Amar M, Vanel D. Response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy: assessment with dynamic and static MR imaging and skeletal scintigraphy. Invest Radiol. 1992;27(11):989-91
Shapeero, L. G., Henry-Amar, M., & Vanel, D. (1992). Response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy: assessment with dynamic and static MR imaging and skeletal scintigraphy. Investigative radiology, 27(11), 989-91.
Shapeero, L G, et al. "Response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy: assessment with dynamic and static MR imaging and skeletal scintigraphy." Investigative radiology vol. 27,11 (1992): 989-91.
Shapeero LG, Henry-Amar M, Vanel D. Response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy: assessment with dynamic and static MR imaging and skeletal scintigraphy. Invest Radiol. 1992 Nov;27(11):989-91. PMID: 1464523.
Copy Download .nbib Format: NLM
[Dynamic MR tomography in the diagnosis of inflammatory and tumorous space-occupying lesions of the musculoskeletal system].

RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin

Erlemann R, Sciuk J, Wuisman P, Bene D, Edel G, Ritter J, Peters PE.
PMID: 1571517
Rofo. 1992 Apr;156(4):353-9. doi: 10.1055/s-2008-1032900.

In 216 inflammatory and tumorous lesions of bone and soft tissue, dynamic Gd-DTPA enhanced MR imaging was performed. For that purpose, 12 FLASH sequences (TR = 40 ms/TE = 10 ms/NSA = 2/flip angle = 90 degrees) were acquired...

Cite
Erlemann R, Sciuk J, Wuisman P, et al. Dynamische MR-Tomographie in der Diagnostik entzündlicher und tumoröser Raumforderungen des muskuloskelettalen Systems. [Dynamic MR tomography in the diagnosis of inflammatory and tumorous space-occupying lesions of the musculoskeletal system]. Rofo. 1992;156(4):353-9doi: 10.1055/s-2008-1032900.
Erlemann, R., Sciuk, J., Wuisman, P., Bene, D., Edel, G., Ritter, J., & Peters, P. E. (1992). Dynamische MR-Tomographie in der Diagnostik entzündlicher und tumoröser Raumforderungen des muskuloskelettalen Systems. [Dynamic MR tomography in the diagnosis of inflammatory and tumorous space-occupying lesions of the musculoskeletal system]. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 156(4), 353-9. https://doi.org/10.1055/s-2008-1032900
Erlemann, R, et al. "Dynamische MR-Tomographie in der Diagnostik entzündlicher und tumoröser Raumforderungen des muskuloskelettalen Systems." [Dynamic MR tomography in the diagnosis of inflammatory and tumorous space-occupying lesions of the musculoskeletal system]. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin vol. 156,4 (1992): 353-9. doi: https://doi.org/10.1055/s-2008-1032900
Erlemann R, Sciuk J, Wuisman P, Bene D, Edel G, Ritter J, Peters PE. Dynamische MR-Tomographie in der Diagnostik entzündlicher und tumoröser Raumforderungen des muskuloskelettalen Systems. [Dynamic MR tomography in the diagnosis of inflammatory and tumorous space-occupying lesions of the musculoskeletal system]. Rofo. 1992 Apr;156(4):353-9. doi: 10.1055/s-2008-1032900. German. PMID: 1571517.
Copy Download .nbib Format: NLM
Preoperative evaluation of osteosarcoma: value of gadopentetate dimeglumine-enhanced MR imaging.

AJR. American journal of roentgenology

Seeger LL, Widoff BE, Bassett LW, Rosen G, Eckardt JJ.
PMID: 1853820
AJR Am J Roentgenol. 1991 Aug;157(2):347-51. doi: 10.2214/ajr.157.2.1853820.

Decisions regarding the surgical approach in osteosarcoma require accurate assessment of tumor extent. In order to determine whether enhancement with gadopentetate dimeglumine could add clinically significant information to that available with unenhanced MR imaging, 21 patients with osteosarcoma underwent...

Cite
Seeger LL, Widoff BE, Bassett LW, et al. Preoperative evaluation of osteosarcoma: value of gadopentetate dimeglumine-enhanced MR imaging. AJR Am J Roentgenol. 1991;157(2):347-51doi: 10.2214/ajr.157.2.1853820.
Seeger, L. L., Widoff, B. E., Bassett, L. W., Rosen, G., & Eckardt, J. J. (1991). Preoperative evaluation of osteosarcoma: value of gadopentetate dimeglumine-enhanced MR imaging. AJR. American journal of roentgenology, 157(2), 347-51. https://doi.org/10.2214/ajr.157.2.1853820
Seeger, L L, et al. "Preoperative evaluation of osteosarcoma: value of gadopentetate dimeglumine-enhanced MR imaging." AJR. American journal of roentgenology vol. 157,2 (1991): 347-51. doi: https://doi.org/10.2214/ajr.157.2.1853820
Seeger LL, Widoff BE, Bassett LW, Rosen G, Eckardt JJ. Preoperative evaluation of osteosarcoma: value of gadopentetate dimeglumine-enhanced MR imaging. AJR Am J Roentgenol. 1991 Aug;157(2):347-51. doi: 10.2214/ajr.157.2.1853820. PMID: 1853820.
Copy Download .nbib Format: NLM
Assessment of osteosarcoma response to preoperative chemotherapy using dynamic FLASH gadolinium-DTPA-enhanced magnetic resonance mapping.

Investigative radiology

Hanna SL, Parham DM, Fairclough DL, Meyer WH, Le AH, Fletcher BD.
PMID: 1582820
Invest Radiol. 1992 May;27(5):367-73. doi: 10.1097/00004424-199205000-00010.

RATIONALE AND OBJECTIVES: To improve the accuracy of magnetic resonance imaging (MRI) in evaluating the response of osteosarcomas to preoperative chemotherapy, the authors developed a technique of mapping tumor necrosis and viability by quantitating slope values of gadolinium-DTPA (Gd-DTPA)...

Cite
Hanna SL, Parham DM, Fairclough DL, et al. Assessment of osteosarcoma response to preoperative chemotherapy using dynamic FLASH gadolinium-DTPA-enhanced magnetic resonance mapping. Invest Radiol. 1992;27(5):367-73doi: 10.1097/00004424-199205000-00010.
Hanna, S. L., Parham, D. M., Fairclough, D. L., Meyer, W. H., Le, A. H., & Fletcher, B. D. (1992). Assessment of osteosarcoma response to preoperative chemotherapy using dynamic FLASH gadolinium-DTPA-enhanced magnetic resonance mapping. Investigative radiology, 27(5), 367-73. https://doi.org/10.1097/00004424-199205000-00010
Hanna, S L, et al. "Assessment of osteosarcoma response to preoperative chemotherapy using dynamic FLASH gadolinium-DTPA-enhanced magnetic resonance mapping." Investigative radiology vol. 27,5 (1992): 367-73. doi: https://doi.org/10.1097/00004424-199205000-00010
Hanna SL, Parham DM, Fairclough DL, Meyer WH, Le AH, Fletcher BD. Assessment of osteosarcoma response to preoperative chemotherapy using dynamic FLASH gadolinium-DTPA-enhanced magnetic resonance mapping. Invest Radiol. 1992 May;27(5):367-73. doi: 10.1097/00004424-199205000-00010. PMID: 1582820.
Copy Download .nbib Format: NLM
Synovial sarcoma: dynamic contrast-enhanced MR imaging features.

Skeletal radiology

van Rijswijk CS, Hogendoorn PC, Taminiau AH, Bloem JL.
PMID: 11289631
Skeletal Radiol. 2001 Jan;30(1):25-30. doi: 10.1007/s002560000295.

OBJECTIVE: To determine whether previously described so-called malignant dynamic contrast-enhanced magnetic resonance (MR) imaging features--early start, peripheral enhancement and early plateau or washout phase--occur consistently in synovial sarcoma.DESIGN AND PATIENTS: Dynamic contrast-enhanced MR images of 10 patients with histologically...

Cite
van Rijswijk CS, Hogendoorn PC, Taminiau AH, et al. Synovial sarcoma: dynamic contrast-enhanced MR imaging features. Skeletal Radiol. 2001;30(1):25-30doi: 10.1007/s002560000295.
van Rijswijk, C. S., Hogendoorn, P. C., Taminiau, A. H., & Bloem, J. L. (2001). Synovial sarcoma: dynamic contrast-enhanced MR imaging features. Skeletal radiology, 30(1), 25-30. https://doi.org/10.1007/s002560000295
van Rijswijk, C S, et al. "Synovial sarcoma: dynamic contrast-enhanced MR imaging features." Skeletal radiology vol. 30,1 (2001): 25-30. doi: https://doi.org/10.1007/s002560000295
van Rijswijk CS, Hogendoorn PC, Taminiau AH, Bloem JL. Synovial sarcoma: dynamic contrast-enhanced MR imaging features. Skeletal Radiol. 2001 Jan;30(1):25-30. doi: 10.1007/s002560000295. PMID: 11289631.
Copy Download .nbib Format: NLM
Magnetic resonance imaging after incomplete resection of soft tissue sarcoma.

Clinical orthopaedics and related research

Kaste SC, Hill A, Conley L, Shidler TJ, Rao BN, Neel MM.
PMID: 11953612
Clin Orthop Relat Res. 2002 Apr;(397):204-11. doi: 10.1097/00003086-200204000-00025.

Review of magnetic resonance imaging was compared with the pathologic review of reexcision specimens from 24 pediatric patients who had initial incomplete resection for soft tissue sarcoma to determine the accuracy of magnetic resonance imaging in detecting residual tumor....

Cite
Kaste SC, Hill A, Conley L, et al. Magnetic resonance imaging after incomplete resection of soft tissue sarcoma. Clin Orthop Relat Res. 2002;(397):204-11doi: 10.1097/00003086-200204000-00025.
Kaste, S. C., Hill, A., Conley, L., Shidler, T. J., Rao, B. N., & Neel, M. M. (2002). Magnetic resonance imaging after incomplete resection of soft tissue sarcoma. Clinical orthopaedics and related research, (397), 204-11. https://doi.org/10.1097/00003086-200204000-00025
Kaste, Sue C, et al. "Magnetic resonance imaging after incomplete resection of soft tissue sarcoma." Clinical orthopaedics and related research vol. ,397 (2002): 204-11. doi: https://doi.org/10.1097/00003086-200204000-00025
Kaste SC, Hill A, Conley L, Shidler TJ, Rao BN, Neel MM. Magnetic resonance imaging after incomplete resection of soft tissue sarcoma. Clin Orthop Relat Res. 2002 Apr;(397):204-11. doi: 10.1097/00003086-200204000-00025. PMID: 11953612.
Copy Download .nbib Format: NLM
Predictors of acute chemotherapy-associated toxicity in patients with Ewing sarcoma.

Pediatric blood & cancer

Sharib JM, Cyrus J, Horvai A, Gray Hazard FK, Neuhaus J, Matthay KK, Goldsby R, Marina N, DuBois SG.
PMID: 22180320
Pediatr Blood Cancer. 2012 Oct;59(4):611-6. doi: 10.1002/pbc.24031. Epub 2011 Dec 16.

BACKGROUND: Ewing sarcoma (ES) is a malignant tumor of bone and soft tissue of children and young adults. Patients with ES are treated with intensive chemotherapy regimens. We describe predictors of acute chemotherapy-associated toxicity in this population.PROCEDURE: In this...

Cite
Sharib JM, Cyrus J, Horvai A, et al. Predictors of acute chemotherapy-associated toxicity in patients with Ewing sarcoma. Pediatr Blood Cancer. 2011;59(4):611-6doi: 10.1002/pbc.24031.
Sharib, J. M., Cyrus, J., Horvai, A., Gray Hazard, F. K., Neuhaus, J., Matthay, K. K., Goldsby, R., Marina, N., & DuBois, S. G. (2012). Predictors of acute chemotherapy-associated toxicity in patients with Ewing sarcoma. Pediatric blood & cancer, 59(4), 611-6. https://doi.org/10.1002/pbc.24031
Sharib, Jeremy M, et al. "Predictors of acute chemotherapy-associated toxicity in patients with Ewing sarcoma." Pediatric blood & cancer vol. 59,4 (2012): 611-6. doi: https://doi.org/10.1002/pbc.24031
Sharib JM, Cyrus J, Horvai A, Gray Hazard FK, Neuhaus J, Matthay KK, Goldsby R, Marina N, DuBois SG. Predictors of acute chemotherapy-associated toxicity in patients with Ewing sarcoma. Pediatr Blood Cancer. 2012 Oct;59(4):611-6. doi: 10.1002/pbc.24031. Epub 2011 Dec 16. PMID: 22180320; PMCID: PMC3310949.
Copy Download .nbib Format: NLM
Playing bad cards properly: challenges to improving cure rates in rhabdomyosarcoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Meyer WH.
PMID: 22665547
J Clin Oncol. 2012 Jul 10;30(20):2431-3. doi: 10.1200/JCO.2012.42.4275. Epub 2012 Jun 04.

No abstract available.

Cite
Meyer WH. Playing bad cards properly: challenges to improving cure rates in rhabdomyosarcoma. J Clin Oncol. 2012;30(20):2431-3doi: 10.1200/JCO.2012.42.4275.
Meyer, W. H. (2012). Playing bad cards properly: challenges to improving cure rates in rhabdomyosarcoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 30(20), 2431-3. https://doi.org/10.1200/JCO.2012.42.4275
Meyer, William H. "Playing bad cards properly: challenges to improving cure rates in rhabdomyosarcoma." Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 30,20 (2012): 2431-3. doi: https://doi.org/10.1200/JCO.2012.42.4275
Meyer WH. Playing bad cards properly: challenges to improving cure rates in rhabdomyosarcoma. J Clin Oncol. 2012 Jul 10;30(20):2431-3. doi: 10.1200/JCO.2012.42.4275. Epub 2012 Jun 04. PMID: 22665547.
Copy Download .nbib Format: NLM
In vivo 31P NMR spectroscopy of human musculoskeletal tumors as a measure of response to chemotherapy.

NMR in biomedicine

Möller HE, Vermathen P, Rummeny E, Wörtler K, Wuisman P, Rössner A, Wörmann B, Ritter J, Peters PE.
PMID: 9176889
NMR Biomed. 1996 Dec;9(8):347-58. doi: 10.1002/(SICI)1099-1492(199612)9:8<347::AID-NBM431>3.0.CO;2-3.

The value of in vivo 31P NMR spectroscopy to provide indicators of response to cytostatic chemotherapy was studied in patients with malignant musculoskeletal tumors. Characteristics of untreated cancers were strong signals of PME and PDE, moderately increased Pi and...

Cite
Möller HE, Vermathen P, Rummeny E, et al. In vivo 31P NMR spectroscopy of human musculoskeletal tumors as a measure of response to chemotherapy. NMR Biomed. 1996;9(8):347-58doi: 10.1002/(SICI)1099-1492(199612)9:8<347::AID-NBM431>3.0.CO;2-3.
Möller, H. E., Vermathen, P., Rummeny, E., Wörtler, K., Wuisman, P., Rössner, A., Wörmann, B., Ritter, J., & Peters, P. E. (1996). In vivo 31P NMR spectroscopy of human musculoskeletal tumors as a measure of response to chemotherapy. NMR in biomedicine, 9(8), 347-58. https://doi.org/10.1002/(SICI)1099-1492(199612)9:8<347::AID-NBM431>3.0.CO;2-3
Möller, H E, et al. "In vivo 31P NMR spectroscopy of human musculoskeletal tumors as a measure of response to chemotherapy." NMR in biomedicine vol. 9,8 (1996): 347-58. doi: https://doi.org/10.1002/(SICI)1099-1492(199612)9:8<347::AID-NBM431>3.0.CO;2-3
Möller HE, Vermathen P, Rummeny E, Wörtler K, Wuisman P, Rössner A, Wörmann B, Ritter J, Peters PE. In vivo 31P NMR spectroscopy of human musculoskeletal tumors as a measure of response to chemotherapy. NMR Biomed. 1996 Dec;9(8):347-58. doi: 10.1002/(SICI)1099-1492(199612)9:8<347::AID-NBM431>3.0.CO;2-3. PMID: 9176889.
Copy Download .nbib Format: NLM
Islet cell tumors: comparison of dynamic contrast-enhanced CT and MR imaging with dynamic gadolinium enhancement and fat suppression.

Radiology

Semelka RC, Cumming MJ, Shoenut JP, Magro CM, Yaffe CS, Kroeker MA, Greenberg HM.
PMID: 8381551
Radiology. 1993 Mar;186(3):799-802. doi: 10.1148/radiology.186.3.8381551.

Ten patients with 11 islet cell tumors underwent dynamic contrast material-enhanced computed tomography (CT) and magnetic resonance (MR) imaging within a 1-month period. MR imaging depicted all 11 tumors, and CT depicted seven of the 11 tumors. CT did...

Cite
Semelka RC, Cumming MJ, Shoenut JP, et al. Islet cell tumors: comparison of dynamic contrast-enhanced CT and MR imaging with dynamic gadolinium enhancement and fat suppression. Radiology. 1993;186(3):799-802doi: 10.1148/radiology.186.3.8381551.
Semelka, R. C., Cumming, M. J., Shoenut, J. P., Magro, C. M., Yaffe, C. S., Kroeker, M. A., & Greenberg, H. M. (1993). Islet cell tumors: comparison of dynamic contrast-enhanced CT and MR imaging with dynamic gadolinium enhancement and fat suppression. Radiology, 186(3), 799-802. https://doi.org/10.1148/radiology.186.3.8381551
Semelka, R C, et al. "Islet cell tumors: comparison of dynamic contrast-enhanced CT and MR imaging with dynamic gadolinium enhancement and fat suppression." Radiology vol. 186,3 (1993): 799-802. doi: https://doi.org/10.1148/radiology.186.3.8381551
Semelka RC, Cumming MJ, Shoenut JP, Magro CM, Yaffe CS, Kroeker MA, Greenberg HM. Islet cell tumors: comparison of dynamic contrast-enhanced CT and MR imaging with dynamic gadolinium enhancement and fat suppression. Radiology. 1993 Mar;186(3):799-802. doi: 10.1148/radiology.186.3.8381551. PMID: 8381551.
Copy Download .nbib Format: NLM
MR imaging of peritoneal disease: comparison of contrast-enhanced fast multiplanar spoiled gradient-recalled and spin-echo imaging.

AJR. American journal of roentgenology

Low RN, Sigeti JS.
PMID: 7976889
AJR Am J Roentgenol. 1994 Nov;163(5):1131-40. doi: 10.2214/ajr.163.5.7976889.

OBJECTIVE: We performed this study to compare contrast-enhanced fast multiplanar spoiled gradient-recalled (SPGR) MR imaging with unenhanced spin-echo imaging for the detection of benign and malignant peritoneal abnormalities.MATERIALS AND METHODS: We retrospectively reviewed abdominal MR images of 34 patients...

Cite
Low RN, Sigeti JS. MR imaging of peritoneal disease: comparison of contrast-enhanced fast multiplanar spoiled gradient-recalled and spin-echo imaging. AJR Am J Roentgenol. 1994;163(5):1131-40doi: 10.2214/ajr.163.5.7976889.
Low, R. N., & Sigeti, J. S. (1994). MR imaging of peritoneal disease: comparison of contrast-enhanced fast multiplanar spoiled gradient-recalled and spin-echo imaging. AJR. American journal of roentgenology, 163(5), 1131-40. https://doi.org/10.2214/ajr.163.5.7976889
Low, R N, and Sigeti, J S. "MR imaging of peritoneal disease: comparison of contrast-enhanced fast multiplanar spoiled gradient-recalled and spin-echo imaging." AJR. American journal of roentgenology vol. 163,5 (1994): 1131-40. doi: https://doi.org/10.2214/ajr.163.5.7976889
Low RN, Sigeti JS. MR imaging of peritoneal disease: comparison of contrast-enhanced fast multiplanar spoiled gradient-recalled and spin-echo imaging. AJR Am J Roentgenol. 1994 Nov;163(5):1131-40. doi: 10.2214/ajr.163.5.7976889. PMID: 7976889.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 165 entries